Mario Gabelli Gilead Sciences, Inc. Transaction History

Gamco Investors, Inc. Et Al

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 06, 2020	SELL	$62.1 - $78.08 $172,389 - $216,750	-2,776 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $519,401 - $603,120	-7,180 Reduced 72.12%	2,776 $214,000
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $623,544 - $798,670	9,956 New	9,956 $744,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $362,325 - $398,546	-5,880 Closed	0 $0
Q3 2019 Nov 01, 2019	SELL	$62.51 - $69.0 $65,635 - $72,450	-1,050 Reduced 15.15%	5,880 $373,000
Q2 2019 Aug 02, 2019	SELL	$61.87 - $69.38 $159,005 - $178,306	-2,570 Reduced 27.05%	6,930 $468,000
Q1 2019 May 02, 2019	SELL	$62.53 - $70.05 $211,351 - $236,769	-3,380 Reduced 26.24%	9,500 $618,000
Q4 2018 Jan 30, 2019	SELL	$60.54 - $79.0 $121,080 - $158,000	-2,000 Reduced 13.44%	12,880 $806,000
Q3 2018 Nov 02, 2018	SELL	$71.28 - $78.92 $7,128 - $7,892	-100 Reduced 0.67%	14,880 $1.15 Million
Q2 2018 Aug 10, 2018	BUY	$64.88 - $75.68 $129,759 - $151,360	2,000 Added 15.41%	14,980 $1.06 Million
Q1 2018 May 09, 2018	SELL	$72.84 - $88.8 $43,704 - $53,280	-600 Reduced 4.42%	12,980 $979,000
Q3 2017 Nov 01, 2017	BUY	$72.11 - $85.47 $979,253 - $1.16 Million	13,580	13,580 $1.1 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.